SPY436.31-6.34 -1.43%
DIA344.89-3.72 -1.07%
IXIC14,668.80-301.17 -2.01%

Jefferies Initiates Coverage On ATAI Life Sciences with Buy Rating, Announces Price Target of $27

Jefferies analyst Andrew Tsai initiates coverage on ATAI Life Sciences (NASDAQ:ATAI) with a Buy rating and announces Price Target of $27.

Benzinga · 09/01/2021 08:22
Jefferies analyst Andrew Tsai initiates coverage on ATAI Life Sciences (NASDAQ:ATAI) with a Buy rating and announces Price Target of $27.